These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Modafinil for people with schizophrenia or related disorders. Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767 [TBL] [Abstract][Full Text] [Related]
15. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Dold M; Samara MT; Li C; Tardy M; Leucht S Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299 [TBL] [Abstract][Full Text] [Related]
16. Antioxidant treatments for schizophrenia. Magalhães PV; Dean O; Andreazza AC; Berk M; Kapczinski F Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008919. PubMed ID: 26848926 [TBL] [Abstract][Full Text] [Related]
17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
18. Zotepine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Jan; (1):CD006628. PubMed ID: 20091601 [TBL] [Abstract][Full Text] [Related]
19. Chlorpromazine versus piperacetazine for schizophrenia. Eslami Shahrbabaki M; Dehnavieh R; Vali L; Sharafkhani R Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011709. PubMed ID: 30378678 [TBL] [Abstract][Full Text] [Related]